Biostar Pharmaceuticals Revenue Quarterly YoY Growth:
-41.16% for Dec. 31, 2012Biostar Pharmaceuticals Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -41.16% |
| Sept. 30, 2012 | -59.77% |
| June 30, 2012 | -68.51% |
| March 31, 2012 | 3.99% |
| Dec. 31, 2011 | -8.11% |
| Sept. 30, 2011 | 22.80% |
| June 30, 2011 | 33.60% |
| March 31, 2011 | 23.67% |
| Dec. 31, 2010 | 65.66% |
| Sept. 30, 2010 | 29.71% |
| June 30, 2010 | 46.44% |
| March 31, 2010 | 66.00% |
| Dec. 31, 2009 | 68.37% |
| Sept. 30, 2009 | 106.3% |
| June 30, 2009 | 40.59% |
| March 31, 2009 | 9.36% |
| Dec. 31, 2008 | 96.72% |
| Sept. 30, 2008 | 43.46% |
| June 30, 2008 | 141.2% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
BSPM Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | -7.20% |
| Tetraphase Pharmaceuticals | 1651% |
| Zoetis | 4.11% |
BSPM Revenue Quarterly YoY Growth Rankings
| Overall |
41st percentile 4688 of 8002 |
| Sector |
32nd percentile 459 of 684 in Healthcare |
| Industry |
42nd percentile 31 of 54 in Drug Manufacturers - Major |
BSPM Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -68.51% | Jun 2012 |
| Maximum | 141.2% | Jun 2008 |
| Average | 32.65% |
BSPM News
Biostar Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 16
Seeking Alpha May 16
Biostar Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcript
Seeking Alpha Apr 15
Seeking Alpha Apr 15